Pim G N J Mutsaers Selected Research

Pim G N J Mutsaers Research Topics

7	Neoplasms (Cancer) 07/2023 - 07/2004
5	COVID-19 07/2023 - 01/2022
2	B-Cell Lymphoma (Lymphoma, B Cell) 08/2023 - 10/2022
2	T-Cell Lymphoma (Lymphoma, T Cell) 11/2022 - 01/2022
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2022 - 01/2022
2	Multiple Myeloma 10/2022 - 01/2022
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2023
1	Bronchiolitis Obliterans Syndrome 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2022
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 12/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021

3	Chimeric Antigen ReceptorsIBA 08/2023 - 01/2022
2	AntibodiesIBA 07/2023 - 10/2022
2	Immunoglobulin G (IgG)IBA 07/2023 - 01/2022
2	Etoposide (VP 16)FDA LinkGeneric 11/2022 - 01/2022
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2022 - 01/2022
2	Vincristine (Oncovin)FDA LinkGeneric 11/2022 - 01/2022
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2022 - 01/2022
2	Prednisone (Sone)FDA LinkGeneric 11/2022 - 01/2022
2	ibrutinibIBA 10/2022 - 01/2022
2	2019-nCoV Vaccine mRNA-1273IBA 10/2022 - 01/2022
1	Proteins (Proteins, Gene)FDA Link 07/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 07/2023
1	Messenger RNA (mRNA)IBA 07/2023
1	Cell-Free Nucleic AcidsIBA 01/2023
1	Rituximab (Mabthera)FDA Link 11/2022
1	Neutralizing AntibodiesIBA 10/2022
1	AnthracyclinesIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	ruxolitinibIBA 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 12/2021

4	Therapeutics 08/2023 - 01/2022
3	Drug Therapy (Chemotherapy) 01/2022 - 07/2004
2	Cell Transplantation 10/2022 - 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2022
1	Aftercare (After-Treatment) 10/2022
1	Transplantation 10/2022